Quinazoline derivatives for the treatment of cancer

The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I wherein Q1 is CR1, Q2 is N, Q4 and Q5 are each CR1, Q3 is CR2, X1 is N or CRc, Y is CRc, X2 and X3 are each C(R5)(R6), R7 is O. Compounds of Formula I are useful in the treatment of diseases and/or...

Full description

Saved in:
Bibliographic Details
Main Authors HUANG KENNETH HE, OMMEN ANDY, BARTA THOMAS, MA WEI, VEAL JAMES, SMITH EMILIE D
Format Patent
LanguageEnglish
Published 16.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I wherein Q1 is CR1, Q2 is N, Q4 and Q5 are each CR1, Q3 is CR2, X1 is N or CRc, Y is CRc, X2 and X3 are each C(R5)(R6), R7 is O. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer The current invention is also directed toward pharmaceutical compositions comprising compounds of the invention.
Bibliography:Application Number: US20070844584